ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.16
-0.57%
US Tech 100
18,258.80
0.46%
S&P 500
5,291.34
0.15%
US Dollar vs CAD
1.36849
0.06%
Bitcoin
70,863.87
0.34%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Purple Biotech Ltd (PPBT)

  7. Purple Biotech Ltd (PPBT) News

PPBT Purple Biotech Ltd

0.62
0.00 (0.00%)
Pre Market
Last Updated: 04:33:47
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Purple Biotech Ltd PPBT NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 0.62 04:33:47
Open Price Low Price High Price Close Price Previous Close
0.62
more quote information »

Recent News

Date Time Source Heading
6/04/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/03/202405:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/01/202407:00GLOBEPurple Biotech Announces Positive Late-Breaking Interim..
5/21/202406:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/21/202406:30GLOBEPurple Biotech Reports First Quarter 2024 Financial Results
4/25/202406:00GLOBEPurple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer..
3/28/202406:00GLOBEPurple Biotech to Present New Data On its Oncology Drug..
3/14/202406:30GLOBEPurple Biotech Reports Preclinical Proof of Concept for its..
3/06/202415:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/05/202415:00EDGAR2Form 20-F - Annual and transition report of foreign private..
3/05/202406:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/05/202406:55GLOBEPurple Biotech Reports Fourth Quarter and Full-Year 2023..
2/27/202406:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/27/202406:00GLOBEPurple Biotech Presents Data of its Phase 1 Head & Neck..
2/13/202406:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/13/202406:00GLOBEPurple Biotech Convenes a Head & Neck Cancer Scientific..
2/01/202406:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/01/202406:30GLOBEPurple Biotech Reaches Recommended Phase 2 Dose for NT219
1/26/202415:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/202307:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/20/202307:05GLOBEPurple Biotech Appoints Dr. Yael Margolin to its Board of..
12/14/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/14/202305:50GLOBEPurple Biotech Completes Patient Enrollment in Phase 2..
11/21/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/21/202305:50GLOBEPurple Biotech Reports Third Quarter 2023 Financial Results
11/14/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/14/202315:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/13/202315:11EDGAR2Form F-1/A - Registration statement for certain foreign..
11/02/202306:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/02/202306:00GLOBEPurple Biotech Fortifies NT219 Patent Protection
10/30/202315:30EDGAR2Form F-1 - Registration statement for certain foreign..
10/19/202315:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/19/202315:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/19/202314:55GLOBEPurple Biotech Announces Closing of $5 Million Registered..
10/19/202309:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/19/202309:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/17/202307:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/17/202307:00GLOBEPurple Biotech Announces $5 Million Registered Direct..
10/17/202306:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/202306:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/06/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/06/202306:50GLOBEPurple Biotech Reports Potential Biomarker Data Support..
10/03/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/03/202306:50GLOBEPurple Biotech Reports Positive Interim and Preliminary..
9/21/202307:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/21/202307:00GLOBEPurple Biotech to Present New CM24 Pancreatic Cancer..
9/13/202307:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/22/202308:29GLOBEPurple Biotech Reports Second Quarter 2023 Financial Results
8/22/202307:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/11/202307:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

NASDAQ
PPBT
Purple Biotech
TG
CXD
Cenovus Energy
COIN
NESTUST
NEST
COIN
PYLNTEUR
Pylon Network
LSE
ETC
Establishment Investment
LSE
BGLF
Blackstone Loan Financing
BIT
P20IB2
NLBNPIT20IB2 20991231 11...
GATE
SXPUSD
Swipe
BIT
F18193
Vontobel Financial Produ...
AMEX
ITDD
iShares Lifepath Target ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved